Toward Closing the Loop between Infrastructure Investments and Societal and Economic Impacts

The long-term value proposition of transportation infrastructure investments can be significantly distorted if the short term effects of spatial externalities on land-use patterns, economic expansions, and migration patterns are not properly included in the analysis. Some of these effects occur over a short period of time and soon after the investment materializes, while others take longer and follow more steady patterns. In this paper, we develop a novel dynamical model of a primal society with constructs that are specifically geared toward transportation infrastructure expansions and investments. The model quantifies the impact of these expansions on some key performance indicators and on the overall utility and production capacity of the society. We argue that traditional analytical models that work on the premises of stationary behavior and a static response of society to changes in infrastructure do not correctly capture these effects. The land use patterns and spatial expansion computed from the model are validated against existing theory on land use. Preliminary results on how to use the model for value proposition analysis are also presented using simple case studies.This is the author accepted manuscript. The final version is available from Taylor & Francis via http://dx.doi.org/10.1080/0013791X.2015.106535

Effect of gonadotropin-releasing hormone (GnRH) treatment on multiple births in Afshari ewes

The purpose of this study was to investigate the effects of gonadotropin-releasing hormone (GnRH) administration on the induction of multiple births in synchronized Afshari ewes. 16 cycling, multiparous fat-tailed Iranian Afshari ewes, weighing 66.5 ± 2.5 kg, were used in the trail. Estrus was synchronized using controlled internal drug release CIDR’s; inserted for 14 days. Pregnant mare serum gonadotrophin (PMSG) (300 IU) was injected to ewes a day before CIDR removal. The ewes was randomly allocated to two groups (n = 8). Synchronization treatment was initiated with a week interval in two groups (weeks 1 and 2). 24 h following CIDR removal (day 1), GnRH (50 μg) was administered to half of each group ewes (GnRH and control groups), and ewes mated with the proven rams. Pregnancy was diagnosed with the aid of transabdominal ultrasonograpy 30 days after mating. Ovarian follicular activity was monitored with the aid of transrectal ultrasonograpy on the days of CIDR removal and at estrus (approximately day 1). Following PMSG treatment, the mean number of large follicles on total ovaries increased from CIDR removal to estrus 1.48 ± 0.71 vs. 2.85 ± 0.82 (P < 0.05). Lambing rate in GnRH group (162.5%) was higher (P < 0.05) compared to the control group (125%). The mean weights of lambs born in the GnRH and control groups were 5.5 ± 0.1 and 5.2 ± 0.1, respectively.Key words: GnRH, estrus synchronization, Afshari, ewe, lambing rate

Cluster Analysis and Model Comparison Using Smart Meter Data.

Load forecasting plays a crucial role in the world of smart grids. It governs many aspects of the smart grid and smart meter, such as demand response, asset management, investment, and future direction. This paper proposes time-series forecasting for short-term load prediction to unveil the load forecast benefits through different statistical and mathematical models, such as artificial neural networks, auto-regression, and ARIMA. It targets the problem of excessive computational load when dealing with time-series data. It also presents a business case that is used to analyze different clusters to find underlying factors of load consumption and predict the behavior of customers based on different parameters. On evaluating the accuracy of the prediction models, it is observed that ARIMA models with the (P, D, Q) values as (1, 1, 1) were most accurate compared to other values

Evaluation of the sleep modulating effects of methanolic extracts of Strychnos spinosa and Strychnos innocua fruits in mice

This study aimed to evaluate the sleep modulating properties of Strychnos spinosa and Strychnos innocua fruits in Swiss albino mice. The depressant effect of the extracts on the central nervous system was studied using a diazepam-induced sleep model in mice. The mice were divided into four groups of six mice each. The test groups received Strychnos spinosa and Strychnos innocua fruits extracts at the doses of 250, 500, and 1000 mg/kg body weight intraperitoneally. In contrast, the control group received distilled water at 10 ml/kg. Diazepam (Ranbaxy®, India) was used as a standard drug and administered 30 minutes after the initial treatment. The lethal doses (LD50) of the two extracts were estimated to be >5000 mg/kg. The results obtained from the onset of sleep of rats administered methanol extracts of Strychnos spinosa, and Strychnos innocua fruits showed that the extracts at 250, 500, and 1000 mg/kg, respectively, did not significantly (p >0.05) alter the onset of sleep when compared with the control. The onset of sleep in the groups treated with Strychnos spinosa fruit extracts indicated a dose-dependent decrease pattern. The study also revealed a prolonged duration of sleep in all the experimental groups treated with the two extracts compared to the control group. The treated groups of 250, 500 and 1000 mg/kg significantly (p <0.05) prolonged the duration of diazepam-induced sleep in a dose-dependent manner when compared to the control group. The group treated with 1000 mg/kg of Strychnos innocua fruit extract was significant (p <0.05) compared to the control group. In conclusion, the high LD50 observed in this study suggests that the two extracts are relatively safe and contain promising bioactive ingredients that cause sleep modulation in mice

Thyroidectomy under local anaesthesia: how safe?

In order to compliment the inadequate health facilities in the rural areas in Nigeria, nongovernmental organisations provide adhoc outreach health camps that offer treatment in various medical specialties including surgery. Rural outreach health camps. To evaluate the safety of thyroidectomy under local anaesthesia at rural outreach setting with inadequate facilities for general anaesthesia. This was a prospective descriptive study of 33 consecutive cases of thyroidectomy performed using field block with 1% lignocaine and adrenaline 1: 200,000 dilution during two free medical outreaches that held at Jos,Nigeria inMarch andOctober 2005 respectively, lasting twoweeks each. : A total of 33 primary thyroid operations were performed consisting of 30 subtotal thyroidectomies (91%), 2 lobectomies (6%) and one total thyroidectomy (3%), The patientswere aged between 23 and 62 years with a mean age of 45.8years. There were 3males and 30 females with a male: female ratio of 1:10. There was no mortality butmorbidity was 2/33 (6%) Two complications were recorded in 2 patients and were superficial surgical site infection (3%) and reactionary haemorrhage (3%). We conclude that thyroidectomy under local anaesthesia is a safe procedure in experienced hands at rural settingswith inadequate facilities for general anaesthesia. Keywords: Thyroidectomy; Local anaesthesia; Safety;Rural outreach;Nigeria Nigerian Journal of Clinical Practice Vol. 11 (1) 2008: pp.37-4

Physical mapping of a powdery mildew resistance related gene Hv-S/TPK by FISH with a TAC clone in wheat

Dissertação de mestrado integrado em Medicina (Hematologia), apresentado á Faculdade de Medicina da Universidade de Coimbra.A Policitemia Vera (PV) é uma doença clonal de etiologia desconhecida, na maior parte dos casos, que envolve a célula estaminal progenitora hematopoiética multipotencial. É uma neoplasia mieloproliferativa crónica (NMP) que se caracteriza pela expansão das três linhas celulares hematopoiéticas: eritróide, granulocítica e megacariocítica, com predomínio da primeira, de modo independente dos mecanismos normais de regulação da eritropoiese. Além disso, as células têm aspecto morfológico normal, a fibrose medular é pouco significativa e os níveis de eritropoietina (Epo) são habitualmente normais a baixos. Além da hipercelularidade medular com sobreprodução de uma ou de todas as linhas celulares, a doença cursa com hematopoiese extramedular, hiperviscosidade, propensão para complicações como trombose ou hemorragia e risco de desenvolvimento de mielofibrose ou transformação em leucemia aguda. A descrição relativamente recente da associação de uma mutação no gene JAK2, localizado no cromosoma 9p24, com as doenças mieloproliferativas clássicas negativas para BCR-ABL, como a PV, veio permitir avanços significativos na compreensão da patofisiologia deste grupo de doenças hematológicas. A mutação provoca uma alteração do aminoácido V (valina) para F (fenilalanina) na posição 617 (JAK2V617F). De acordo com os dados publicados, a frequência da detecção da mutação JAK2V617F em doentes com PV é de cerca de 95%. A proteína JAK2 é uma tirosina cinase citoplasmática, que se encontra associada ao domínio intracelular dos receptores de citocinas (como a Epo e trombopoietina - Tpo), e de factores de crescimento, essenciais para a função destes receptores. A mutação da JAK2 conduz à activação constitutiva dos receptores, independente da ligação à respectiva citocina e/ou hipersensibilidade a factores de crescimento, com consequente activação de múltiplas vias de sinalização intracelulares como a JAK/STAT (Janus Kinase/Signal Transductor and activator of transcription), a PI3K (fosfatidilinositol 3 cinase) e a MAPK (proteína cinase activadora de mitose), envolvidas na transformação e proliferação dos progenitores hematopoiéticos. Por outro lado, as células evidenciam alteração na diferenciação terminal e resistência à apoptose in vitro que poderá estar relacionada com o aumento da expressão da proteína anti-apoptótica Bcl-XL. Além dos avanços no diagnóstico, a detecção da mutação JAK2V617F tem contribuido para melhorar a classificação e a terapêutica dos doentes com PV. Deste modo, o conhecimento dos mecanismos moleculares envolvidos na PV tem levado os investigadores à descoberta de novos fármacos dirigidos ao defeito molecular, permitindo novas abordagem terapêuticas mais eficazes e provavelmente de menor toxicidade. Este trabalho procura fazer uma revisão sobre o actual conhecimento da caracterização molecular e clínica da PV e quais as suas implicações no diagnóstico e abordagem terapêutica desta NMP.Polycythemia Vera (PV) is a clonal disease of unknown etiology, which often involves the pluripotential hematopoietic stem cell. This disease integrates the family of chronic myeloproliferative neoplasm (MPN) and is characterized by the growth of the three hematopoietic celular lineages: granulocytic, megakaryocytic and erythroid, with predominance of the last one and regardless the normal mechanisms of erythropoiesis regulation. Moreover, cells have normal morphological aspect, bone marrow shows slight fibrosis and the levels of erythropoietin (Epo) usually vary from normal to low. Besides marrow hypercellularity with overproduction of one or all the celular lineages, the disease courses with extramedullary hematopoiesis, hyperviscosity, leading to complications such as thrombosis or bleeding and risk of transformation to myelofibrosis or acute leukemia. Recently it has been described the association between the mutation in the JAK2 gene, located on chromosome 9p24, with the classic myeloproliferative disorders BCR-ABL negative, such as PV, which has brought significant advances in the understanding of the pathophysiology of this group of hematologic malignancies. The mutation causes a change of amino acid V (valine) to F (phenylalanine) at position 617 (JAK2V617F). According to published data, the frequency of JAK2V617F mutation detected in patients with PV is about 95%. JAK2 protein is a cytoplasmic tyrosine kinase, which is associated to the intracelular domain of cytokine receptors, such as Epo and thrombopoietin (Tpo), and growth factors which are essential to the function of these receptors. JAK2 mutation leads to the constitutive receptors activation, independent of connection to their cytokine and / or hypersensitivity to growth factors, with consequent activation of multiple intracellular signaling pathways such as JAK / STAT (Janus Kinase / Signal transducer and transcription activator), the PI3K (phosphatidylinositol 3 kinase) and MAPK (Mitogen-activated protein), involved in the transformation and proliferation of hematopoietic progenitors. Moreover, the cells show changes in terminal differentiation and resistance to in vitro apoptosis which is possibly related to the increasing expression of anti-apoptotic protein Bcl-XL. In addition to the advances in diagnosis, detection of JAK2V617F mutation has contributed to the improvement of classification and treatment in patients with PV. Thus, knowledge of the molecular mechanisms involved in PV has led investigators to the discovery of new drugs targeting molecular defects, allowing new therapeutic approach more efficient and probably less toxic. The aim of this article is to review the current knowledge of clinical and molecular characterization of PV, and its implications on the diagnosis and therapeutic approach of this myeloproliferative disorder

Effectiveness of a pharmacist-led educational intervention to reduce the use of high-risk abbreviations in an acute care setting in Saudi Arabia: A quasi-experimental study

Objectives: To evaluate the effectiveness of a pharmacist-led educational intervention to reduce the use of high-risk abbreviations (HRAs) by healthcare professionals. Design: Quasi-experimental study consisting of a single group before-and-after study design. Setting: A public emergency hospital in Mecca, Saudi Arabia. Participants: 660 (preintervention) and then 498 (postintervention) handwritten physician orders, medication administration records (MRAs) and pharmacy dispensing sheets of 482 and 388 patients, respectively, from emergency wards, inpatient settings and the pharmacy department were reviewed. Intervention: The intervention consisted of a series of interactive lectures delivered by an experienced clinical pharmacist to all hospital staff members and dissemination of educational tools (flash cards, printed list of HRAs, awareness posters) designed in line with the recommendations of the Institute for Safe Medical Practices and the US Food and Drug Administration. The duration of intervention was from April to May 2011. Main outcome: Reduction in the incidence of HRAs use from the preintervention to postintervention study period. Findings: The five most common abbreviations recorded prior to the interventions were 'IJ for injection' (28.6%), 'SC for subcutaneous' (17.4%), drug name and dose running together (9.7%), 'OD for once daily' (5.8%) and 'D/C for discharge' (4.3%). The incidence of the use of HRAs was highest in discharge prescriptions and dispensing records (72.7%) followed by prescriptions from in-patient wards (47.3%). After the intervention, the overall incidence of HRA was significantly reduced by 52% (ie, 53.6% vs 25.5%; p=0.001). In addition, there was a statistically significant reduction in the incidence of HRAs across all three settings: the pharmacy department (72.7% vs 39.3%), inpatient settings (47.3% vs 23.3%) and emergency wards (40.9% vs 10.7%). Conclusions: Pharmacist-led educational interventions can significantly reduce the use of HRAs by healthcare providers. Future research should investigate the long-term effectiveness of such educational interventions through a randomised controlled trial

Role of vanadium ions substitution on spinel MnCo2O4 towards enhanced electrocatalytic activity for hydrogen generation

This is the final version. Available on open access from Nature Research via the DOI in this recordData availability: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.Improving efficient electrocatalysts (ECs) for hydrogen generation through water splitting is of significant interest in tackling the upcoming energy crisis. Sustainable hydrogen generation is the primary prerequisite to realizing the future hydrogen economy. This work examines the electrocatalytic activity of hydrothermally prepared vanadium doped MnCo spinel oxide microspheres (MC), MnVxCo2−xO4 (Vx-MnCo MC, where x ≤ 0.4) in the HER (hydrogen evolution reaction) process. Magnetization measurements demonstrated a paramagnetic (at high temperatures) to a ferrimagnetic (at low temperatures) transition below the Curie temperature (Tc) in all the samples. The magnetization is found to intensify with the rising vanadium content of MCs. The optimized catalyst Vx-MnCo MCs (x = 0.3) outperformed other prepared ECs with a Tafel slope of 84 mV/dec, a low onset potential of 78.9 mV, and a low overpotential of 85.9 mV at a current density of 10 mA/cm2, respectively. The significantly improved HER performance of hydrothermally synthesized Vx-MnCo MCs (x = 0.3) is principally attributable to many exposed active sites, accelerated electron transport at the EC/electrolyte interface, and remarkable electron spectroscopy for chemical analysis (ECSA) value was found ~ 11.4 cm2. Moreover, the Vx-MnCo MCs (x = 0.3) electrode exhibited outstanding electrocatalytic stability after exposure to 1000 cyclic voltametric cycles and 36 h of chronoamperometric testing. Our results suggest a feasible route for developing earth-abundant transition metal oxide-based EC as a superior electrode for future water electrolysis applications.British CouncilKACARE Fellowshi